OBIO® receives funding from the Ontario government to bring new technologies to market

Today, the Ontario government announced that the Ontario Bioscience Innovation Organization (OBIO®) will receive $9.7 million to support their program to help Ontario companies in the life sciences sector to adopt, develop and bring to market critical technologies, such as 5G, ethical artificial intelligence (AI), blockchain, cybersecurity, quantum and robotics. 

The new funding, through the province’s Critical Technology Initiatives program, will help OBIO® launch a new Life Sciences Critical Technologies & Commercialization Centre of Excellence alongside its delivery partners. The centre of excellence will use a hub and spoke model to help small and medium-sized businesses in the life sciences sector adopt, develop and bring to market critical technologies, and will include access to two 5G living labs in Ottawa and Toronto. 

"We are grateful for this new funding, which will enable us to support companies through the adoption, development and commercialization of critical technologies, a key driver for the Ontario life sciences sector," said Maura Campbell, President and CEO of OBIO®. "We look forward to working with our partners to launch the Life Sciences Critical Technologies Centre of Excellence, ensuring that Ontario-made technology companies are supported in the province to become international market leaders."  

We acknowledge the Ontario government for their continued support of OBIO®.  

Previous
Previous

ImmunoBiochem enters a deal with ImmunoGen to develop next-generation antibody-drug conjugates

Next
Next

SheBoot goes national to fuel the success of women entrepreneurs across Canada